vs

Side-by-side financial comparison of Immunocore Holdings plc (IMCR) and Repay Holdings Corp (RPAY). Click either name above to swap in a different company.

Immunocore Holdings plc is the larger business by last-quarter revenue ($104.5M vs $78.6M, roughly 1.3× Repay Holdings Corp). On growth, Immunocore Holdings plc posted the faster year-over-year revenue change (24.3% vs 0.4%). Repay Holdings Corp produced more free cash flow last quarter ($23.2M vs $-35.5M). Over the past eight quarters, Immunocore Holdings plc's revenue compounded faster (21.7% CAGR vs -1.3%).

Immunocore is a global commercial-stage biotechnology company, based in Oxfordshire, which researches and develops biological drugs using soluble T-cell receptor technology.

Repay Holdings Corp is a leading payment technology provider delivering integrated end-to-end payment processing solutions for businesses across North America. Its offerings include credit/debit card processing, ACH transfer services, POS system integrations and digital payment tools, serving retail, healthcare, automotive and e-commerce segments to help clients streamline transaction workflows and boost operational efficiency.

IMCR vs RPAY — Head-to-Head

Bigger by revenue
IMCR
IMCR
1.3× larger
IMCR
$104.5M
$78.6M
RPAY
Growing faster (revenue YoY)
IMCR
IMCR
+23.9% gap
IMCR
24.3%
0.4%
RPAY
More free cash flow
RPAY
RPAY
$58.8M more FCF
RPAY
$23.2M
$-35.5M
IMCR
Faster 2-yr revenue CAGR
IMCR
IMCR
Annualised
IMCR
21.7%
-1.3%
RPAY

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
IMCR
IMCR
RPAY
RPAY
Revenue
$104.5M
$78.6M
Net Profit
$-140.1M
Gross Margin
97.4%
74.2%
Operating Margin
-18.8%
-182.2%
Net Margin
-178.3%
Revenue YoY
24.3%
0.4%
Net Profit YoY
-3304.1%
EPS (diluted)
$-0.61
$-1.68

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IMCR
IMCR
RPAY
RPAY
Q4 25
$104.5M
$78.6M
Q3 25
$103.7M
$77.7M
Q2 25
$98.0M
$75.6M
Q1 25
$93.9M
$77.3M
Q4 24
$84.1M
$78.3M
Q3 24
$80.2M
$79.1M
Q2 24
$75.4M
$74.9M
Q1 24
$70.5M
$80.7M
Net Profit
IMCR
IMCR
RPAY
RPAY
Q4 25
$-140.1M
Q3 25
$-177.0K
$-6.4M
Q2 25
$-10.3M
$-102.3M
Q1 25
$5.0M
$-7.9M
Q4 24
$-4.1M
Q3 24
$8.7M
$3.2M
Q2 24
$-11.6M
$-4.1M
Q1 24
$-24.4M
$-5.2M
Gross Margin
IMCR
IMCR
RPAY
RPAY
Q4 25
97.4%
74.2%
Q3 25
99.5%
74.4%
Q2 25
98.9%
75.7%
Q1 25
99.1%
75.9%
Q4 24
99.6%
76.3%
Q3 24
99.4%
77.8%
Q2 24
97.7%
78.2%
Q1 24
99.7%
76.2%
Operating Margin
IMCR
IMCR
RPAY
RPAY
Q4 25
-18.8%
-182.2%
Q3 25
-6.9%
-3.9%
Q2 25
-15.2%
-138.7%
Q1 25
-3.9%
-4.7%
Q4 24
-23.1%
-1.5%
Q3 24
-10.6%
-0.9%
Q2 24
-21.2%
-4.6%
Q1 24
-37.6%
-3.1%
Net Margin
IMCR
IMCR
RPAY
RPAY
Q4 25
-178.3%
Q3 25
-0.2%
-8.3%
Q2 25
-10.5%
-135.2%
Q1 25
5.4%
-10.3%
Q4 24
-5.3%
Q3 24
10.9%
4.1%
Q2 24
-15.4%
-5.4%
Q1 24
-34.7%
-6.5%
EPS (diluted)
IMCR
IMCR
RPAY
RPAY
Q4 25
$-0.61
$-1.68
Q3 25
$0.00
$-0.08
Q2 25
$-0.20
$-1.15
Q1 25
$0.10
$-0.09
Q4 24
$-0.47
$-0.04
Q3 24
$0.17
$0.03
Q2 24
$-0.23
$-0.04
Q1 24
$-0.49
$-0.06

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IMCR
IMCR
RPAY
RPAY
Cash + ST InvestmentsLiquidity on hand
$864.2M
$115.7M
Total DebtLower is stronger
$280.1M
Stockholders' EquityBook value
$381.0M
$484.4M
Total Assets
$1.1B
$1.2B
Debt / EquityLower = less leverage
0.58×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IMCR
IMCR
RPAY
RPAY
Q4 25
$864.2M
$115.7M
Q3 25
$892.4M
$95.7M
Q2 25
$882.8M
$162.6M
Q1 25
$837.0M
$165.5M
Q4 24
$820.4M
$189.5M
Q3 24
$901.3M
$168.7M
Q2 24
$859.6M
$147.1M
Q1 24
$832.8M
$128.3M
Total Debt
IMCR
IMCR
RPAY
RPAY
Q4 25
$280.1M
Q3 25
$279.5M
Q2 25
$279.0M
Q1 25
$497.6M
Q4 24
$496.8M
Q3 24
$438.7M
$496.2M
Q2 24
$452.5M
$435.6M
Q1 24
$452.5M
$434.9M
Stockholders' Equity
IMCR
IMCR
RPAY
RPAY
Q4 25
$381.0M
$484.4M
Q3 25
$396.6M
$616.9M
Q2 25
$388.5M
$633.7M
Q1 25
$378.5M
$755.7M
Q4 24
$360.7M
$761.3M
Q3 24
$377.8M
$754.7M
Q2 24
$359.1M
$815.4M
Q1 24
$359.5M
$813.8M
Total Assets
IMCR
IMCR
RPAY
RPAY
Q4 25
$1.1B
$1.2B
Q3 25
$1.1B
$1.3B
Q2 25
$1.1B
$1.4B
Q1 25
$1.0B
$1.5B
Q4 24
$1.0B
$1.6B
Q3 24
$1.1B
$1.6B
Q2 24
$1.0B
$1.5B
Q1 24
$994.0M
$1.5B
Debt / Equity
IMCR
IMCR
RPAY
RPAY
Q4 25
0.58×
Q3 25
0.45×
Q2 25
0.44×
Q1 25
0.66×
Q4 24
0.65×
Q3 24
1.16×
0.66×
Q2 24
1.26×
0.53×
Q1 24
1.26×
0.53×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IMCR
IMCR
RPAY
RPAY
Operating Cash FlowLast quarter
$-32.7M
$23.3M
Free Cash FlowOCF − Capex
$-35.5M
$23.2M
FCF MarginFCF / Revenue
-34.0%
29.6%
Capex IntensityCapex / Revenue
2.8%
0.1%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-15.1M
$90.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IMCR
IMCR
RPAY
RPAY
Q4 25
$-32.7M
$23.3M
Q3 25
$-4.5M
$32.2M
Q2 25
$26.0M
$33.1M
Q1 25
$435.0K
$2.5M
Q4 24
$-14.0M
$34.3M
Q3 24
$21.1M
$60.1M
Q2 24
$23.5M
$31.0M
Q1 24
$-4.6M
$24.8M
Free Cash Flow
IMCR
IMCR
RPAY
RPAY
Q4 25
$-35.5M
$23.2M
Q3 25
$-5.2M
$32.1M
Q2 25
$25.6M
$33.0M
Q1 25
$137.0K
$2.4M
Q4 24
$-17.5M
$34.0M
Q3 24
$20.3M
$59.8M
Q2 24
$23.1M
$30.5M
Q1 24
$-5.0M
$24.7M
FCF Margin
IMCR
IMCR
RPAY
RPAY
Q4 25
-34.0%
29.6%
Q3 25
-5.0%
41.3%
Q2 25
26.1%
43.6%
Q1 25
0.1%
3.0%
Q4 24
-20.9%
43.5%
Q3 24
25.3%
75.6%
Q2 24
30.7%
40.7%
Q1 24
-7.1%
30.6%
Capex Intensity
IMCR
IMCR
RPAY
RPAY
Q4 25
2.8%
0.1%
Q3 25
0.7%
0.2%
Q2 25
0.4%
0.1%
Q1 25
0.3%
0.2%
Q4 24
4.3%
0.3%
Q3 24
1.0%
0.3%
Q2 24
0.4%
0.6%
Q1 24
0.6%
0.1%
Cash Conversion
IMCR
IMCR
RPAY
RPAY
Q4 25
Q3 25
Q2 25
Q1 25
0.09×
Q4 24
Q3 24
2.42×
18.52×
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

IMCR
IMCR

Segment breakdown not available.

RPAY
RPAY

Sales Channel Directly To Consumer$69.4M88%
Other$6.8M9%
Sales Channel Through Intermediary$2.3M3%

Related Comparisons